EMEA-001187-PIP01-11-M04 - paediatric investigation plan

tafluprost

Key facts

• Invented name:
  Taflotan and associated names
• Active substance:
  tafluprost
• Therapeutic area:
  Ophthalmology
• Decision number:
  P/0061/2017
• PIP number:
  EMEA-001187-PIP01-11-M04
• Pharmaceutical form(s):
  • Eye drops, solution in single-dose container
  • Eye drops, solution
• Condition(s) / indication(s):
  Treatment of glaucoma
• Route(s) of administration:
  Ocular use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  17/03/2017
• Compliance check done:
  No

Decision

P/0061/2017: EMA decision of 17 March 2017 on the acceptance of a modification of an agreed paediatric investigation plan for tafluprost (Taflotan and associated names), (EMEA-001187-PIP01-11-M04)

Adopted Reference Number: EMA/130759/2017